HighTower Advisors LLC Raises Stock Position in Rockwell Medical, Inc. (NASDAQ:RMTI)

HighTower Advisors LLC lifted its position in Rockwell Medical, Inc. (NASDAQ:RMTI) by 75.6% during the 3rd quarter, HoldingsChannel reports. The firm owned 57,413 shares of the company’s stock after buying an additional 24,715 shares during the period. HighTower Advisors LLC’s holdings in Rockwell Medical were worth $228,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Armistice Capital LLC grew its holdings in shares of Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after purchasing an additional 592,000 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Rockwell Medical by 877.1% during the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after acquiring an additional 92,189 shares during the last quarter. Beacon Financial Advisory LLC purchased a new position in Rockwell Medical in the third quarter worth $98,000. Walleye Capital LLC bought a new position in Rockwell Medical in the third quarter valued at $435,000. Finally, Corsair Capital Management L.P. purchased a new stake in Rockwell Medical during the third quarter valued at about $298,000. Hedge funds and other institutional investors own 23.31% of the company’s stock.

Analyst Ratings Changes

RMTI has been the subject of a number of research reports. Rodman & Renshaw began coverage on Rockwell Medical in a report on Thursday, November 14th. They issued a “buy” rating and a $5.00 price objective for the company. RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. HC Wainwright reaffirmed a “buy” rating and set a $7.00 price objective on shares of Rockwell Medical in a research note on Monday. Finally, StockNews.com lowered Rockwell Medical from a “buy” rating to a “hold” rating in a research note on Friday, December 20th.

Rockwell Medical Stock Up 1.9 %

Shares of NASDAQ RMTI opened at $2.15 on Wednesday. The company has a market cap of $69.49 million, a price-to-earnings ratio of -43.00 and a beta of 1.38. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The firm’s fifty day moving average is $2.86 and its 200 day moving average is $2.71. Rockwell Medical, Inc. has a 52 week low of $1.16 and a 52 week high of $5.15.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.